Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Study shows smoking is associated with a higher likelihood of COVID-19 progression

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

13 Jul 2020

History of rape associated with 'dysfunctional breathing'

Rape and sexual trauma may have long-lasting consequences for physical health as well as mental health, University of Otago researchers have found.

11 Jul 2020

Scientists identify a new role for covalent linker in transmembrane ion channels

In the molecular-level world of ion channels - passageways through membranes that carry signals in a cell's environment and allow it to respond - researchers have debated about the role of a small piece of the channel called a linker, says computational biophysicist Jianhan Chen at the University of Massachusetts Amherst.

10 Jul 2020

Study of 17 million patients pinpoints COVID-19 mortality risk factors

Now, an analysis of 17 million people in England, the most extensive study of its kind, sheds light on certain factors that can increase a person’s chances of dying from COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Jul 2020

Asthma sufferers can use inhalers amid COVID-19 concerns

The benefits of using inhalers and nebulizers containing steroids outweigh the risks despite warnings to the contrary during the COVID-19 pandemic, a study by University of Huddersfield researchers has found.

9 Jul 2020

Proximity to natural environments benefits formula-fed babies' gut microbiome

Living close to natural green space can mitigate some of the changes in infant gut bacteria associated with formula feeding, according to new research published in the journal Environment International.

9 Jul 2020

Could Trump’s push to undo the ACA cause problems for COVID survivors? Biden thinks so.

The same day the Trump administration reaffirmed its support of a lawsuit that would invalidate all of the Affordable Care Act, Joe Biden sharply warned that the suit endangers millions of Americans.

9 Jul 2020

Health care providers should increase access to nature, indicates study

While access to nature is an established social determinant of health with clear benefits to physical, mental, and social health, it does not receive as must attention by health care providers or health systems as other social concerns, according to a new piece by a Penn Medicine physician published today in the American Journal of Preventive Medicine.

9 Jul 2020

Community development initiative reduced rates of high-cost care, study finds

More than a decade into the community development initiative called Healthy Neighborhoods Healthy Families, the 30-block Southern Orchards neighborhood on Columbus, Ohio's South Side had clear, notable improvement. Home vacancy fell from 30% to under 6%.

8 Jul 2020

Parent‐specific effects on child's risk of developing asthma and allergies

New research found that, compared with a father's traits related to allergies and asthma, a mother's traits create a higher risk that a child will develop these same traits in early childhood.

8 Jul 2020

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical trial to test common asthma inhalers as a treatment for COVID-19 infection.

8 Jul 2020

Asthma inhalers being trialed for treatment of COVID-19

Researchers from Queensland University of Technology and Oxford University are working in collaboration to begin human clinical trials of inhaled corticosteroids, commonly used for asthma patients, on patients with COVID-19. The researchers believe that this could be useful for patients with the novel coronavirus infection.

7 Jul 2020

Gene expression networks flag potential therapeutic targets for SARS-CoV-2

An international team of researchers from Canada, Australia, the Netherlands, and the United States has identified dozens of genes that could contribute to the pathology of coronavirus disease 2019 (COVID-19) and serve as potential therapeutic targets.

7 Jul 2020

Researchers develop peptides for treating gastrointestinal disorders

The fascinating family of trefoil factor peptides brings hope to both research and industry to improve the treatment of chronic disorders such as Crohn's disease.

7 Jul 2020

'Night owl' teens more likely to develop asthma and allergies

Teenagers who prefer to stay up late at night and sleep in late the next day are more likely to develop asthma and allergies than their "early bird" counterparts, according to new research published today.

6 Jul 2020

Asthma does not appear to increase the risk of COVID-19, shows study

Asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity, according to a team of Rutgers researchers.

6 Jul 2020

Study: Teenagers who stay up late are more likely to suffer from asthma, allergies

Teenagers who prefer to stay up late and wake later in the morning are more likely to suffer from asthma and allergies compared to those who sleep and wake earlier, according to a study published in ERJ Open Research.

6 Jul 2020

Research suggests protective effect of influenza vaccine against COVID-19 severity and mortality

A new study involving over 92,000 patients with COVID-19 in Brazil shows that the odds of severe disease, ventilatory support requirement, and death are reduced with a recent trivalent flu vaccine. This seems to indicate that these vaccines should be used as widely as possible to reduce the risk of severe COVID-19, especially among high-risk groups. The study is published on the preprint server medRxiv* in June 2020.

5 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020